000			01608 a2200493 4500
005			20250517013848.0
264		0	_c20150930
008			201509s 0 0 eng d
022			_a1445-4866
040			_aNLM _beng _cNLM
100	1		_aLahra, Monica M
245	0	0	_aAustralian Meningococcal Surveillance Programme annual report, 2013. _h[electronic resource]
260			_bCommunicable diseases intelligence quarterly report _cDec 2014
300			_aE301-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Distribution
650	0	4	_aAged
650	0	4	_aAnnual Reports as Topic
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aAustralia _xepidemiology
650	0	4	_aCeftriaxone _xtherapeutic use
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCiprofloxacin _xtherapeutic use
650	0	4	_aEpidemiological Monitoring
650	0	4	_aGene Expression
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aMeningococcal Infections _xdiagnosis
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMiddle Aged
650	0	4	_aNeisseria meningitidis _xdrug effects
650	0	4	_aPenicillins _xpharmacology
650	0	4	_aPhenotype
650	0	4	_aPorins _xgenetics
650	0	4	_aRifampin _xtherapeutic use
650	0	4	_aSerotyping
650	0	4	_abeta-Lactam Resistance
700	1		_aEnriquez, Rodney P
773	0		_tCommunicable diseases intelligence quarterly report _gvol. 38 _gno. 4 _gp. E301-8
999			_c24575220 _d24575220